COMPANY NAME	REVENUES 12 Months Ending Q3 2018	MARKET SHARE 12 Months Q3 2018	MARKET SHARE MRQ Q3 2018	MARKET SHARE A Quarter Before Q2 2018
Neos Therapeutics Inc	42.38	1.31%	30.18 %	27.79 %
Regencell Bioscience Holdings Limited	3,068.30	95.12%	0.00%	0.00%
Zevra Therapeutics Inc	115.07	3.57%	69.82%	72.21%

NEOS's Market share relative to its competitors, as of Q3 2018 within the Major Pharmaceutical Preparations Industry

As of Q3 2018

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2018	MARKET SHARE 12 Months Ending Q2 2018	MARKET SHARE MRQ Q3 2018	MARKET SHARE Q2 2018
Neos Therapeutics Inc	26.92%	25.57%	30.18 %	27.79 %
Zevra Therapeutics Inc	73.08%	74.43%	69.82%	72.21%

NEOS's Market share relative to its competitors, as of Q3 2018 within the Healthcare Sector

As of Q3 2018

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2018	MARKET SHARE 12 Months Ending Q2 2018	MARKET SHARE MRQ Q3 2018	MARKET SHARE Q2 2018
Neos Therapeutics Inc	26.92%	25.57%	30.18 %	27.79 %
Zevra Therapeutics Inc	73.08%	74.43%	69.82%	72.21%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Neos Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Neos Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.